Ultrapotent chemogenetics for research and potential clinical applications
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Improved agonists for chemogenetics: Targeting ligand-responsive receptors to specific groups of cells, a strategy known as chemogenetics, is a powerful tool in many neurological applications. There is increasing interest in extending these tools for human treatment. Magnus et al. designed chemogenetic ion channels that improve currently available systems and are activated by the clinically used antismoking drug varenicline. They engineered a ligand-binding domain less responsive to endogenous signals and identified agonists that function at nanomolar concentrations. The combination of drug and introduced channels transiently silenced neurons, with slow but effective washout, and induced behavioral changes in animal models after brain administration. Science , this issue p. eaav5282
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S., & Roth, B. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700293104 · Cited by 2,046 · cited 1×
“Chemogenetic systems (table S1) based on engineered G protein–coupled receptors (GPCRs) calledDREADDs have been usedwith the agonist clozapine-N-oxide (CNO) (8, 9), but CNO is a substrate for the P-glycoprotein efflux pump (PgP) and ismetabolically converted to clozapine, which is the active agent in the brain (5, 6,…”
BackgroundRoth, B. L. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.040 · Cited by 1,742
Imaging large-scale neural activity with cellular resolution in awake, mobile mice
Dombeck, D. A., Khabbaz, A. N., Collman, F., Adelman, T. L., & Tank, D. W. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.003 · Cited by 1,099
Chemogenetics revealed: DREADD occupancy and activation via converted clozapine
Gomez, J. L., Bonaventura, J., Lesniak, W., Mathews, W. B., Sysa-Shah, P., Rodriguez, L. A., Ellis, R. J., Richie, C. T., Harvey, B. K., Dannals, R. F., et al. (2017) · Science · doi:10.1126/science.aan2475 · Cited by 980
Self-citationDeconstruction of a neural circuit for hunger
Atasoy, D., Betley, J. N., Su, H. H., & Sternson, S. M. (2012) · Nature · doi:10.1038/nature11270 · Cited by 969
Self-citationAutomated design of ligands to polypharmacological profiles
Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., et al. (2012) · Nature · doi:10.1038/nature11691 · Cited by 832 · cited 1×
“To test for binding to a larger range of molecular targets, we used radioligand displacement against functionally important endogenous receptors and transporters (37).”
MethodPrefrontal Acetylcholine Release Controls Cue Detection on Multiple Timescales
Parikh, V., Kozak, R., Martinez, V., & Sarter, M. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.025 · Cited by 623
Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors
Mihalak, K. B., Carroll, F. I., & Luetje, C. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025130 · Cited by 558
Sublayer-Specific Coding Dynamics during Spatial Navigation and Learning in Hippocampal Area CA1
Danielson, N. B., Zaremba, J. D., Kaifosh, P., Bowler, J., Ladow, M., & Losonczy, A. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.020 · Cited by 288
Rollema, H., Shrikhande, A., Ward, K., Tingley III, F., Coe, J., O'Neill, B., Tseng, E., Wang, E., Mather, R., Hurst, R., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00682.x · Cited by 162 · cited 3×
“Varenicline is an especially attractive molecule for chemogenetic applications in the central nervous system because (i) it is well-tolerated by patients at low doses (16, 17), (ii) it has excellent brain penetrance (18), (iii) it is not a PgP substrate (19), (iv) it has low binding to plasma proteins, and (v) it has…”
Cited by
Nagai, Y., Miyakawa, N., Takuwa, H., Hori, Y., Oyama, K., Ji, B., Takahashi, M., Huang, X.-P., Slocum, S. T., DiBerto, J. F., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0661-3 · Cited by 410
Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans
Vormstein-Schneider, D., Lin, J. D., Pelkey, K. A., Chittajallu, R., Guo, B., Arias-Garcia, M. A., Allaway, K., Sakopoulos, S., Schneider, G., Stevenson, O., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0692-9 · Cited by 235
Wu, X., Jiang, Y., Rommelfanger, N. J., Yang, F., Zhou, Q., Yin, R., Liu, J., Cai, S., Ren, W., Shin, A., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00862-w · Cited by 222
“Similar to our approach, chemogenetics does not require any brain implants or head tethering, but is limited by the relatively coarse temporal resolution of neuronal manipulation 26,27 .”
InfluentialNeuronal dynamics direct cerebrospinal fluid perfusion and brain clearance
Jiang-Xie, L.-F., Drieu, A., Bhasiin, K., Quintero, D., Smirnov, I., & Kipnis, J. (2024) · Nature · doi:10.1038/s41586-024-07108-6 · Cited by 220
Integrative neurocircuits that control metabolism and food intake
Brüning, J. C., & Fenselau, H. (2023) · Science · doi:10.1126/science.abl7398 · Cited by 214
“Therefore, development of improved opto-or chemogenet-ic tools alongside the more defined identification of targetable critical neuronal nodes in metabolic control may lead to the development of gene therapeutic approaches for the remote control of feeding behavior and systemic metabolism ( 153 ).”
Thalamocortical interactions in cognition and disease: The mediodorsal and anterior thalamic nuclei
Perry, B. A. L., Lomi, E., & Mitchell, A. S. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.032 · Cited by 62
Spatiotemporally resolved protein synthesis as a molecular framework for memory consolidation
Shrestha, P., & Klann, E. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.01.004 · Cited by 54
“Burgeoning development of neurochemical sensors [19,20], light, and designer molecule-gated neural activity modulators [21 – 23] have advanced our knowledge of these cell types, as well as critical circuit components of various memory modules.”
Basal ganglia-spinal cord pathway that commands locomotor gait asymmetries in mice
Cregg, J. M., Sidhu, S. K., Leiras, R., & Kiehn, O. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01569-8 · Cited by 48
“Previous work has demonstrated that broad inhibition of SNr neurons induces contralateral turning 45,46 .”
BackgroundEngineered stem cells by emerging biomedical stratagems
Wang, J., Zhang, X., Chen, H., Ren, H., Zhou, M., & Zhao, Y. (2024) · Science Bulletin · doi:10.1016/j.scib.2023.12.006 · Cited by 37
Circuit mechanisms for disentangled representations and generalization in the hippocampus
Tang, W., Chang, H., Liu, C., Perez-Hernandez, S., Zheng, W. Y., Park, J., Karaba, L. A., Oliva, A., & Fernandez-Ruiz, A. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02491-x
Metadata
- Authors
- Magnus, C. J., Lee, P. H., Bonaventura, J., Zemla, R., Gomez, J. L., Ramirez, M. H., Hu, X., Galvan, A., Basu, J., Michaelides, M., & Sternson, S. M.
- Venue
- Science
- Published
- 2019-04-12
- Volume
- 364
- Issue
- 6436
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2922284851
- Cited by
- 190
- References
- 11
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.